Replies to post #2130 on Enanta Pharmaceuticals Inc (ENTA)

[vinmantoo]

The main differences between the 1/11/22 slide set and the previous (11/18/21) slide set are in slide #15 (EDP-323 info) and #30 (2022 news flow).

Thanks Dew for the cliff notes version. In slide 30 they mention select a third mechanism for HBV combination regimen with EDP-514. I assume the second mechanism will be a nucleoside analog, right?